Project description
A real-world remedy for clinical trial failures
Product development in the medical industry usually takes years to materialise and success is not guaranteed. In fact, 85 % of new therapies tested never reach the market because they fail to demonstrate quality, safety or efficacy. Products that pass clinical trials may also fail after they reach the market due to unanticipated side effects. To boost success rates, the EU-funded RWEal project is developing a life analytics platform to provide high-quality, accurate and reliable real-world evidence (RWE) to clinical trials. This will prove useful as clinical trials cannot account for the entire patient population for a particular ailment. Medical product developers will benefit from insights that can only be gained outside the controlled environment of the clinic.
Fields of science
- natural sciencescomputer and information sciencesartificial intelligence
- natural sciencescomputer and information sciencesdata science
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensors
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
20521 Turku
Finland
See on map